FDA Inspection
Novartis d.o.o.Novartis d.o.o. – FDA Inspection, Sep 11, 2020
Record Details
This FDA Inspection record concerns Novartis d.o.o., with an inspection on September 11, 2020, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Novartis d.o.o.
- Inspection Date
- September 11, 2020
- Product Type
- Drugs
View Company Profile
ID · 4bf055c1-d709-40df-8e9a-cbe4a310aab7
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1155320
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Novartis d.o.o.
6| Date | Classification | Office | Project area |
|---|---|---|---|
| July 21, 2023 | Not classified | Office of Inspections and Investigations | |
| September 21, 2022 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 13, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 18, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 19, 2012 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Novartis d.o.o.
- FDA Inspection 1215215 - 2023-07-21
- FDA Inspection 1228827 - 2022-09-21
- FDA Inspection 1004338 - 2017-02-13
- FDA Inspection 945699 - 2015-09-18
- FDA Inspection 807398 - 2012-10-19
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.